Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2013

Open Access 01-12-2013 | Research

Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers

Authors: Hellas Cena, Antonella Tesone, Rosanna Niniano, Isa Cerveri, Carla Roggi, Giovanna Turconi

Published in: Diabetology & Metabolic Syndrome | Issue 1/2013

Login to get access

Abstract

Background

Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking.

Methods

In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy.
All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication.

Results

The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed.

Conclusions

Currently smoking subjects are at high risk of developing the metabolicsyndrome.
Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age.
Literature
2.
go back to reference Frati AC, Iniestra F, Ariza CR: Acute effect of cigarette smoking on glucose tolerance and othercardiovascular risk factors. Diabetes Care. 1996, 19: 112-118. 10.2337/diacare.19.2.112.CrossRefPubMed Frati AC, Iniestra F, Ariza CR: Acute effect of cigarette smoking on glucose tolerance and othercardiovascular risk factors. Diabetes Care. 1996, 19: 112-118. 10.2337/diacare.19.2.112.CrossRefPubMed
3.
go back to reference Targher G, Alberiche M, Zenere MB, et al: Cigarette smoking and insulin resistance in patients withnoninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1997, 82: 3619-3624. 10.1210/jc.82.11.3619.PubMed Targher G, Alberiche M, Zenere MB, et al: Cigarette smoking and insulin resistance in patients withnoninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1997, 82: 3619-3624. 10.1210/jc.82.11.3619.PubMed
4.
go back to reference Wada T, Urashima M, Fukumoto T: Risk of metabolic syndrome persists twenty years after the cessation ofsmoking. Intern Med. 2007, 46: 1079-1082. 10.2169/internalmedicine.46.0026.CrossRefPubMed Wada T, Urashima M, Fukumoto T: Risk of metabolic syndrome persists twenty years after the cessation ofsmoking. Intern Med. 2007, 46: 1079-1082. 10.2169/internalmedicine.46.0026.CrossRefPubMed
5.
go back to reference Lee WY, Jung CH, Park JS, et al: Effects of smoking, alcohol, exercise, education, and family history on themetabolic syndrome as defined by the ATP III. Diabetes Res Clin Pract. 2005, 67: 70-77. 10.1016/j.diabres.2004.05.006.CrossRefPubMed Lee WY, Jung CH, Park JS, et al: Effects of smoking, alcohol, exercise, education, and family history on themetabolic syndrome as defined by the ATP III. Diabetes Res Clin Pract. 2005, 67: 70-77. 10.1016/j.diabres.2004.05.006.CrossRefPubMed
6.
go back to reference Tsiara S, Elisaf M, Mikhailidis DP: Influence of smoking on predictors of vascular disease. Angiology. 2003, 54: 507-530. 10.1177/000331970305400501.CrossRefPubMed Tsiara S, Elisaf M, Mikhailidis DP: Influence of smoking on predictors of vascular disease. Angiology. 2003, 54: 507-530. 10.1177/000331970305400501.CrossRefPubMed
7.
go back to reference Steiner G, Schwartz L, Shumak S, et al: The association of increased levels of intermediate-density lipoproteins withsmoking and with coronary artery disease. Circulation. 1987, 75: 124-130. 10.1161/01.CIR.75.1.124.CrossRefPubMed Steiner G, Schwartz L, Shumak S, et al: The association of increased levels of intermediate-density lipoproteins withsmoking and with coronary artery disease. Circulation. 1987, 75: 124-130. 10.1161/01.CIR.75.1.124.CrossRefPubMed
8.
go back to reference Criqui MH, Wallace RB, Heiss G, et al: Cigarette smoking and plasma high-density lipoprotein cholesterol. The LipidResearch Clinics Program Prevalence Study. Circulation. 1980, 62: IV70-IV76.PubMed Criqui MH, Wallace RB, Heiss G, et al: Cigarette smoking and plasma high-density lipoprotein cholesterol. The LipidResearch Clinics Program Prevalence Study. Circulation. 1980, 62: IV70-IV76.PubMed
9.
go back to reference Cena H, Fonte ML, Turconi G: Relationship between smoking and Metabolic Syndrome. Nutr Rev. 2011, 69 (12): 745-753. 10.1111/j.1753-4887.2011.00446.x.CrossRefPubMed Cena H, Fonte ML, Turconi G: Relationship between smoking and Metabolic Syndrome. Nutr Rev. 2011, 69 (12): 745-753. 10.1111/j.1753-4887.2011.00446.x.CrossRefPubMed
10.
go back to reference Miyatake N, Wada J, Kawasaki Y, et al: Relationship between metabolic syndrome and cigarette smoking in the Japanesepopulation. Intern Med. 2006, 45: 1039-1043. 10.2169/internalmedicine.45.1850.CrossRefPubMed Miyatake N, Wada J, Kawasaki Y, et al: Relationship between metabolic syndrome and cigarette smoking in the Japanesepopulation. Intern Med. 2006, 45: 1039-1043. 10.2169/internalmedicine.45.1850.CrossRefPubMed
11.
go back to reference Geslain-Biquez C, Vol S, Tichet J, et al: The metabolic syndrome in smokers. The D.E.S.I.R. study. Diabetes Metab. 2003, 29: 226-234. 10.1016/S1262-3636(07)70031-9.CrossRefPubMed Geslain-Biquez C, Vol S, Tichet J, et al: The metabolic syndrome in smokers. The D.E.S.I.R. study. Diabetes Metab. 2003, 29: 226-234. 10.1016/S1262-3636(07)70031-9.CrossRefPubMed
12.
go back to reference Weitzman M, Cook S, Auinger P, et al: Tobacco smoke exposure is associated with the metabolic syndrome inadolescents. Circulation. 2005, 112: 862-869. 10.1161/CIRCULATIONAHA.104.520650.CrossRefPubMed Weitzman M, Cook S, Auinger P, et al: Tobacco smoke exposure is associated with the metabolic syndrome inadolescents. Circulation. 2005, 112: 862-869. 10.1161/CIRCULATIONAHA.104.520650.CrossRefPubMed
13.
go back to reference Saarni SE, Pietilainen K, Kantonen S, et al: Association of smoking in adolescence with abdominal obesity in adulthood: afollow-up study of 5 birth cohorts of Finnish twins. Am J Public Health. 2009, 99: 348-354. 10.2105/AJPH.2007.123851.PubMedCentralCrossRefPubMed Saarni SE, Pietilainen K, Kantonen S, et al: Association of smoking in adolescence with abdominal obesity in adulthood: afollow-up study of 5 birth cohorts of Finnish twins. Am J Public Health. 2009, 99: 348-354. 10.2105/AJPH.2007.123851.PubMedCentralCrossRefPubMed
14.
go back to reference Kawada T, Otsuka T, Inagaki H, et al: Association of smoking status, insulin resistance, body mass index, andmetabolic syndrome in workers: a 1-year follow-up study. Obes Res Clin Pract. 2010, 4: e163-e169. 10.1016/j.orcp.2009.12.004.CrossRefPubMed Kawada T, Otsuka T, Inagaki H, et al: Association of smoking status, insulin resistance, body mass index, andmetabolic syndrome in workers: a 1-year follow-up study. Obes Res Clin Pract. 2010, 4: e163-e169. 10.1016/j.orcp.2009.12.004.CrossRefPubMed
15.
go back to reference Reaven G, Tsao PS: Insulin resistance and compensatory hyperinsulinemia: the key player betweencigarette smoking and cardiovascular disease?. J Am Coll Cardiol. 2003, 41: 1044-1047. 10.1016/S0735-1097(02)02982-0.CrossRefPubMed Reaven G, Tsao PS: Insulin resistance and compensatory hyperinsulinemia: the key player betweencigarette smoking and cardiovascular disease?. J Am Coll Cardiol. 2003, 41: 1044-1047. 10.1016/S0735-1097(02)02982-0.CrossRefPubMed
16.
go back to reference Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfoldthickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974, 32 (1): 77-97. 10.1079/BJN19740060.CrossRefPubMed Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfoldthickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974, 32 (1): 77-97. 10.1079/BJN19740060.CrossRefPubMed
17.
go back to reference Li Y, Swensen SJ, Karabekmez LG, et al: Effect of Emphysema on Lung Cancer Risk in Smokers: A ComputedTomography-based Assessment. Cancer Prev Res. 2011, 4 (1): 43-50. 10.1158/1940-6207.CAPR-10-0151.CrossRef Li Y, Swensen SJ, Karabekmez LG, et al: Effect of Emphysema on Lung Cancer Risk in Smokers: A ComputedTomography-based Assessment. Cancer Prev Res. 2011, 4 (1): 43-50. 10.1158/1940-6207.CAPR-10-0151.CrossRef
18.
go back to reference Forey BA, Thornton AJ, Lee PN: Systematic review with meta-analysis of the epidemiological evidence relatingsmoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med. 2011, 11: 36-10.1186/1471-2466-11-36.PubMedCentralCrossRefPubMed Forey BA, Thornton AJ, Lee PN: Systematic review with meta-analysis of the epidemiological evidence relatingsmoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med. 2011, 11: 36-10.1186/1471-2466-11-36.PubMedCentralCrossRefPubMed
19.
go back to reference Assmann G, Guerra R, Fox G, et al: Harmonizing the definition of the metabolic syndrome: comparison of thecriteria of the Adult Treatment Panel III and the International DiabetesFederation in United States American and European populations. Am J Cardiol. 2007, 99: 541-548. 10.1016/j.amjcard.2006.08.045.CrossRefPubMed Assmann G, Guerra R, Fox G, et al: Harmonizing the definition of the metabolic syndrome: comparison of thecriteria of the Adult Treatment Panel III and the International DiabetesFederation in United States American and European populations. Am J Cardiol. 2007, 99: 541-548. 10.1016/j.amjcard.2006.08.045.CrossRefPubMed
20.
go back to reference Alberti KG, Eckel RH, Grundy SM, National Heart, Lung, and Blood Institute, et al: Harmonizing the metabolic syndrome: a joint interim statement of theInternational Diabetes Federation Task Force on Epidemiology andPrevention. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, National Heart, Lung, and Blood Institute, et al: Harmonizing the metabolic syndrome: a joint interim statement of theInternational Diabetes Federation Task Force on Epidemiology andPrevention. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
21.
go back to reference Alberti KG, Zimmet P: Shaw Metabolic syndrome–a new world-wide definition. A ConsensusStatement from the International Diabetes Federation. J Diabetes Med. 2006, 23 (5): 469-480. 10.1111/j.1464-5491.2006.01858.x.CrossRef Alberti KG, Zimmet P: Shaw Metabolic syndrome–a new world-wide definition. A ConsensusStatement from the International Diabetes Federation. J Diabetes Med. 2006, 23 (5): 469-480. 10.1111/j.1464-5491.2006.01858.x.CrossRef
22.
go back to reference Ford ES, Li C, Zhao G: Prevalence and correlates of metabolic syndrome based on a harmoniousdefinition among adults in the US. J Diabetes. 2010, 2 (3): 180-193. 10.1111/j.1753-0407.2010.00078.x.CrossRefPubMed Ford ES, Li C, Zhao G: Prevalence and correlates of metabolic syndrome based on a harmoniousdefinition among adults in the US. J Diabetes. 2010, 2 (3): 180-193. 10.1111/j.1753-0407.2010.00078.x.CrossRefPubMed
23.
go back to reference Grundy SM, Cleeman JI, Daniels SR, et al: American Heart Association; National Heart, Lung, and Blood Institute.Diagnosis and management of the metabolic syndrome Diagnosis and managementof the metabolic syndrome: an American Heart Association/National Heart,Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112 (17): 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, et al: American Heart Association; National Heart, Lung, and Blood Institute.Diagnosis and management of the metabolic syndrome Diagnosis and managementof the metabolic syndrome: an American Heart Association/National Heart,Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112 (17): 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed
24.
go back to reference Hayes L, Pearce MS, Unwin NC: Lifecourse predictors of normal metabolic parameters in overweight and obeseadults. Int J Obes. 2006, 30 (6): 970-976. 10.1038/sj.ijo.0803213.CrossRef Hayes L, Pearce MS, Unwin NC: Lifecourse predictors of normal metabolic parameters in overweight and obeseadults. Int J Obes. 2006, 30 (6): 970-976. 10.1038/sj.ijo.0803213.CrossRef
25.
go back to reference Wannamethee SG, Shaper AG, Whincup PH: Modifiable lifestyle factors and the metabolic syndrome in older men: Effectsof lifestyle changes. J Am Geriatr Soc. 2006, 54 (12): 1909-1914. 10.1111/j.1532-5415.2006.00974.x.CrossRefPubMed Wannamethee SG, Shaper AG, Whincup PH: Modifiable lifestyle factors and the metabolic syndrome in older men: Effectsof lifestyle changes. J Am Geriatr Soc. 2006, 54 (12): 1909-1914. 10.1111/j.1532-5415.2006.00974.x.CrossRefPubMed
26.
go back to reference Zhu S, St-Onge MP, Heshka S, et al: Lifestyle Behaviors associeted with lower risk of having the MetabolicSyndrome. Metabolism. 2004, 53 (11): 1503-1511. 10.1016/j.metabol.2004.04.017.CrossRefPubMed Zhu S, St-Onge MP, Heshka S, et al: Lifestyle Behaviors associeted with lower risk of having the MetabolicSyndrome. Metabolism. 2004, 53 (11): 1503-1511. 10.1016/j.metabol.2004.04.017.CrossRefPubMed
27.
go back to reference Pinto Pereira SM, Ki M, Power C: Sedentary behaviour and biomarkers for cardiovascular disease and diabetes inmid-life: the role of television-viewing and sitting at work. PLoS One. 2012, 7 (2): e31132-10.1371/journal.pone.0031132.PubMedCentralCrossRefPubMed Pinto Pereira SM, Ki M, Power C: Sedentary behaviour and biomarkers for cardiovascular disease and diabetes inmid-life: the role of television-viewing and sitting at work. PLoS One. 2012, 7 (2): e31132-10.1371/journal.pone.0031132.PubMedCentralCrossRefPubMed
28.
go back to reference Tankó LB, Christiansen C: An update on the antiestrogenic effect of smoking: a literature review withimplications for researchers and practitioners. Menopause. 2004, 11 (1): 104-109. 10.1097/01.GME.0000079740.18541.DB.CrossRefPubMed Tankó LB, Christiansen C: An update on the antiestrogenic effect of smoking: a literature review withimplications for researchers and practitioners. Menopause. 2004, 11 (1): 104-109. 10.1097/01.GME.0000079740.18541.DB.CrossRefPubMed
29.
go back to reference Kwok S, Canoy D, Soran H, et al: Body fat distribution in relation to smoking and exogenous hormones inBritish women. Clin Endocrinol. 2011, 10.1111/j.1365-2265.2011.04331.x. Kwok S, Canoy D, Soran H, et al: Body fat distribution in relation to smoking and exogenous hormones inBritish women. Clin Endocrinol. 2011, 10.1111/j.1365-2265.2011.04331.x.
30.
go back to reference Clair C, Chiolero A, Faeh D, et al: Dose-dependent positive association between cigarette smoking, abdominalobesity and body fat: cross-sectional data from a population-basedsurvey. BMC Public Health. 2011, 11: 23-10.1186/1471-2458-11-23.PubMedCentralCrossRefPubMed Clair C, Chiolero A, Faeh D, et al: Dose-dependent positive association between cigarette smoking, abdominalobesity and body fat: cross-sectional data from a population-basedsurvey. BMC Public Health. 2011, 11: 23-10.1186/1471-2458-11-23.PubMedCentralCrossRefPubMed
31.
go back to reference Chiolero A, Faeh D, Paccaud F, et al: Consequences of smoking for body weight, body fat distribution, and insulinresistance. Am J Clin Nutr. 2008, 87 (4): 801-809.PubMed Chiolero A, Faeh D, Paccaud F, et al: Consequences of smoking for body weight, body fat distribution, and insulinresistance. Am J Clin Nutr. 2008, 87 (4): 801-809.PubMed
32.
go back to reference Shimokata H, Muller DC, Andres R: Studies in the distribution of body fat. Effects of cigarettes smoking. JAMA. 1989, 26: 1169-1173.CrossRef Shimokata H, Muller DC, Andres R: Studies in the distribution of body fat. Effects of cigarettes smoking. JAMA. 1989, 26: 1169-1173.CrossRef
33.
go back to reference Kishida K, Funahashi T, Matsuzawa Y, et al: Visceral adiposity as a target for the management of the metabolicsyndrome. Ann Med. 2011, 44 (3): 233-241.CrossRefPubMed Kishida K, Funahashi T, Matsuzawa Y, et al: Visceral adiposity as a target for the management of the metabolicsyndrome. Ann Med. 2011, 44 (3): 233-241.CrossRefPubMed
34.
go back to reference Petursson H, Sigurdsson JA, Bengtsson C, et al: Body configuration as a predictor of mortality: comparison of fiveanthropometric measures in a 12 year follow-up of the Norwegian HUNT 2study. PLoS One. 2011, 6 (10): e26621-10.1371/journal.pone.0026621.PubMedCentralCrossRefPubMed Petursson H, Sigurdsson JA, Bengtsson C, et al: Body configuration as a predictor of mortality: comparison of fiveanthropometric measures in a 12 year follow-up of the Norwegian HUNT 2study. PLoS One. 2011, 6 (10): e26621-10.1371/journal.pone.0026621.PubMedCentralCrossRefPubMed
35.
go back to reference Will JC, Galuska DA, Ford ES, et al: Cigarette smoking and diabetes mellitus: evidence of a positive associationfrom a large prospective cohort study. Int J Epidemiol. 2001, 30 (3): 540-546. 10.1093/ije/30.3.540.CrossRefPubMed Will JC, Galuska DA, Ford ES, et al: Cigarette smoking and diabetes mellitus: evidence of a positive associationfrom a large prospective cohort study. Int J Epidemiol. 2001, 30 (3): 540-546. 10.1093/ije/30.3.540.CrossRefPubMed
36.
go back to reference Tanko LB: Novel association between bioaviable estradiol and adipokines in ederlywomenwith different phenotypes of obesity: implication for atherogenesis. Circulation. 2004, 110 (15): 2246-2252. 10.1161/01.CIR.0000144470.55149.E5.CrossRefPubMed Tanko LB: Novel association between bioaviable estradiol and adipokines in ederlywomenwith different phenotypes of obesity: implication for atherogenesis. Circulation. 2004, 110 (15): 2246-2252. 10.1161/01.CIR.0000144470.55149.E5.CrossRefPubMed
37.
go back to reference Cryer PE, Haymond MW, Santiago JV, et al: Norepinephrine and epinephrine release and adrenergic mediation ofsmoking-associated hemodynamic and metabolic events. N Engl J Med. 1976, 295 (11): 573-577. 10.1056/NEJM197609092951101.CrossRefPubMed Cryer PE, Haymond MW, Santiago JV, et al: Norepinephrine and epinephrine release and adrenergic mediation ofsmoking-associated hemodynamic and metabolic events. N Engl J Med. 1976, 295 (11): 573-577. 10.1056/NEJM197609092951101.CrossRefPubMed
38.
go back to reference Kannel WB: Cigarettes, coronary occlusion, and myocardial infarction. JAMA. 1981, 246 (8): 871-872. 10.1001/jama.1981.03320080057033.CrossRefPubMed Kannel WB: Cigarettes, coronary occlusion, and myocardial infarction. JAMA. 1981, 246 (8): 871-872. 10.1001/jama.1981.03320080057033.CrossRefPubMed
39.
go back to reference Beaser RS, Levy P: Metabolic syndrome: a work in progress, but a useful construct. Circulation. 2007, 115: 1812-1818. 10.1161/CIRCULATIONAHA.106.673616.CrossRefPubMed Beaser RS, Levy P: Metabolic syndrome: a work in progress, but a useful construct. Circulation. 2007, 115: 1812-1818. 10.1161/CIRCULATIONAHA.106.673616.CrossRefPubMed
40.
go back to reference Eliasson B, Attvall S, Taskinen MR, et al: The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb. 1994, 14 (12): 1946-1950. 10.1161/01.ATV.14.12.1946.CrossRefPubMed Eliasson B, Attvall S, Taskinen MR, et al: The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb. 1994, 14 (12): 1946-1950. 10.1161/01.ATV.14.12.1946.CrossRefPubMed
41.
go back to reference Barter P: Raising HDL-C can be achieved by both lifestyle changes and pharmacologicalmeans. Atheroscler Suppl. 2011, 12 (3): 265-266. 10.1016/S1567-5688(11)00035-3.CrossRefPubMed Barter P: Raising HDL-C can be achieved by both lifestyle changes and pharmacologicalmeans. Atheroscler Suppl. 2011, 12 (3): 265-266. 10.1016/S1567-5688(11)00035-3.CrossRefPubMed
42.
go back to reference Kontush A, Chapman MJ: Antiatherogenic small, dense HDL–guardian angel of the arterialwall?. Nat Clin Pract Cardiovasc Med. 2006, 3 (3): 144-153. 10.1038/ncpcardio0500.CrossRefPubMed Kontush A, Chapman MJ: Antiatherogenic small, dense HDL–guardian angel of the arterialwall?. Nat Clin Pract Cardiovasc Med. 2006, 3 (3): 144-153. 10.1038/ncpcardio0500.CrossRefPubMed
43.
go back to reference Graham I, Atar D, Borch-Johnsen K, et al: European guidelines on cardiovascular disease prevention in clinicalpractice: Fourth Joint Task Force of the European Society of Cardiology andother societies. Eur J Cardiovasc Prev Rehabil. 2007, 14 (Suppl. 2): S1-S113.CrossRefPubMed Graham I, Atar D, Borch-Johnsen K, et al: European guidelines on cardiovascular disease prevention in clinicalpractice: Fourth Joint Task Force of the European Society of Cardiology andother societies. Eur J Cardiovasc Prev Rehabil. 2007, 14 (Suppl. 2): S1-S113.CrossRefPubMed
44.
go back to reference Alberico L, et al, The Task Force for the management of dyslipidaemias of the EuropeanSociety of Cardiology (ESC) and the European Atherosclerosis Society(EAS), Authors/Task Force Members: Review et ESC/EAS Guidelines for the management of dyslipidaemias. Atherosclerosis. 2011, 217S: S1-S44. Alberico L, et al, The Task Force for the management of dyslipidaemias of the EuropeanSociety of Cardiology (ESC) and the European Atherosclerosis Society(EAS), Authors/Task Force Members: Review et ESC/EAS Guidelines for the management of dyslipidaemias. Atherosclerosis. 2011, 217S: S1-S44.
45.
go back to reference Travier N, Agudo A, May A, et al: Longitudinal changes in weight in relation to smoking cessation inparticipants of the EPIC-PANACEA study. Prev Med. 2012, 54 (3–4): 183-192.CrossRefPubMed Travier N, Agudo A, May A, et al: Longitudinal changes in weight in relation to smoking cessation inparticipants of the EPIC-PANACEA study. Prev Med. 2012, 54 (3–4): 183-192.CrossRefPubMed
46.
go back to reference Katano S, Nakamura Y, Nakamura A, et al: Relationship among phisycal activity, smoking, drinking and clustering of theMetabolic Syndrome Diagnostic Components. J Atheroscler Thromb. 2010, 17 (6): 644-650. 10.5551/jat.3699.CrossRefPubMed Katano S, Nakamura Y, Nakamura A, et al: Relationship among phisycal activity, smoking, drinking and clustering of theMetabolic Syndrome Diagnostic Components. J Atheroscler Thromb. 2010, 17 (6): 644-650. 10.5551/jat.3699.CrossRefPubMed
47.
go back to reference Kleppinger A, Litt MD, Kenny AM, et al: Effects of smoking cessation on body composition in postmenopausal women. J Womens Health. 2010, 19 (9): 1651-1657. 10.1089/jwh.2009.1853.CrossRef Kleppinger A, Litt MD, Kenny AM, et al: Effects of smoking cessation on body composition in postmenopausal women. J Womens Health. 2010, 19 (9): 1651-1657. 10.1089/jwh.2009.1853.CrossRef
48.
go back to reference Gorber SC, Tremblay M, Moher D, et al: A comparison of direct vs. self-report measures for assessing height, weightand body mass index: a systematic review. Obes Rev. 2007, 8 (4): 307-326. 10.1111/j.1467-789X.2007.00347.x.CrossRefPubMed Gorber SC, Tremblay M, Moher D, et al: A comparison of direct vs. self-report measures for assessing height, weightand body mass index: a systematic review. Obes Rev. 2007, 8 (4): 307-326. 10.1111/j.1467-789X.2007.00347.x.CrossRefPubMed
Metadata
Title
Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers
Authors
Hellas Cena
Antonella Tesone
Rosanna Niniano
Isa Cerveri
Carla Roggi
Giovanna Turconi
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2013
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-5-28

Other articles of this Issue 1/2013

Diabetology & Metabolic Syndrome 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.